Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium

References

• Lopez-CamposJLRuiz-RamosMSorianoJBMortality trends in chronic obstructive pulmonary disease in Europe, 1994–2010: a joinpoint regression analysisLancet201421546224461902
   PubMed Web of Science ®Google Scholar
• LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010Lancet201238098592095212823245604
   PubMed Web of Science ®Google Scholar
• JansonCMarksGBuistSThe impact of COPD on health status: findings from the BOLD studyEur Res J201342614721483
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJLHartlSPozo-RodriguezFRobertsCMEuropean COPD Audit teamVariability of hospital resources for acute care of COPD patients: the European COPD auditEur Res J2014433754762
   PubMed Web of Science ®Google Scholar
• PauwelsRALöfdahlCGLaitinenLALong-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society study on chronic obstructive pulmonary diseaseN Engl J Med1999340251948195310379018
   PubMed Web of Science ®Google Scholar
• RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
   PubMed Web of Science ®Google Scholar
• VestboJAndersonWCoxsonHOECLIPSE investigatorsEvaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE)Eur Res J2008314869873
   PubMed Web of Science ®Google Scholar
• AgustiACalverleyPMCelliBEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsCharacterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJLBustamanteVMunozXBarreiroEMoving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine-a critical viewChronic Obstr Pulm Dis2014115591602
   Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• ZoggSDurrSMiedingerDStevelingEHMaierSLeuppiJDDifferences in classification of COPD patients into risk groups A–D: a cross-sectional studyBMC Res Notes20147156225148698
   PubMedGoogle Scholar
• JonesPMiravitllesMvan der MolenTKulichKBeyond FEV(1) in COPD: a review of patient-reported outcomes and their measurementInt J Chron Obstruct Pulmon Dis2012769770923093901
   PubMed Web of Science ®Google Scholar
• SingerJPYusenRDDefining patient-reported outcomes in chronic obstructive pulmonary disease: the patient-centered experienceMed Clin North Am201296476778722793944
   PubMed Web of Science ®Google Scholar
• Rutten-van MolkenMPOostenbrinkJBMiravitllesMMonzBUModelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in SpainEur J Health Econ20078212313517370096
   PubMed Web of Science ®Google Scholar
• AlaghaKPalotASofalviTLong-acting muscarinic receptor antagonists for the treatment of chronic airway diseasesTher Adv Chronic Dis201452859824587893
   PubMedGoogle Scholar
• MiravitllesMSoler-CatalunaJJCalleMSpanish guideline for COPD (GesEPOC). Update 2014Arch Bronconeumol201450suppl 111624507959
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSUPLIFT Study InvestigatorsA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• BedardMEBrouillardCPepinVTiotropium improves walking endurance in COPDEur Respir J201239226527121700602
   PubMed Web of Science ®Google Scholar
• MathioudakisAGKanavidisPChatzimavridou-GrigoriadouVTiotropium HandiHaler improves the survival of patients with COPD: a systematic review and meta-analysisJ Aerosol Med Pulm Drug Deliv2014271435023521168
   PubMed Web of Science ®Google Scholar
• WiseRAAnzuetoACottonDTIOSPIR InvestigatorsTiotropium Respimat inhaler and the risk of death in COPDN Engl J Med2013369161491150123992515
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJCosíoBIzquierdoJLConsensus document on the overlap phenotype COPD-asthma in COPDArch Bronconeumol201248933133722341911
   PubMed Web of Science ®Google Scholar
• HardinMChoMMcDonaldMLThe clinical and genetic features of COPD-asthma overlap syndromeEur Respir J201444234135024876173
   PubMed Web of Science ®Google Scholar
• FletcherCMThe clinical diagnosis of pulmonary emphysema; an experimental studyProc R Soc Med195245957758413003946
   PubMedGoogle Scholar
• MahlerDAWeinbergDHWellsCKFeinsteinARThe measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexesChest19848567517586723384
   PubMed Web of Science ®Google Scholar
• WitekTJJrMahlerDAMinimal important difference of the transition dyspnoea index in a multinational clinical trialEur Respir J200321226727212608440
   PubMed Web of Science ®Google Scholar
• DobbelsFde JongCDrostEPROactive consortiumThe PROactive innovative conceptual framework on physical activityEur Respiratory journal201444512231233
   PubMed Web of Science ®Google Scholar
• CrawfordBMonzBHohlfeldJDevelopment and validation of a cough and sputum assessment questionnaireEur Respir Med20081021115451555
   Web of Science ®Google Scholar
• KesslerRPartridgeMRMiravitllesMSymptom variability in patients with severe COPD: a pan-European cross-sectional studyEur Respir J201137226427221115606
   PubMed Web of Science ®Google Scholar
• PartridgeMRKarlssonNSmallIRPatient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet surveyCurr Med Res Opin20092582043204819569976
   PubMed Web of Science ®Google Scholar
• GavaldàAMiralpeixMRamosICharacterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profileJ Pharmacol Exp Ther2009331274075119710368
   PubMed Web of Science ®Google Scholar
• SentellasSRamosIAlbertíJAclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolitesEur J Pharm Sci201039528329020093184
   PubMed Web of Science ®Google Scholar
• de la MotteSBeierJSchmidKPascualSJansatJMGilEGPharmacokinetics and safety of aclidinium bromide in younger and elderly patients with chronic obstructive pulmonary diseaseInt J Clin Pharmacol Ther201250640341222541745
   PubMed Web of Science ®Google Scholar
• KerwinEMD’UrzoADGelbAFACCORD I study investigatorsEfficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I)Chronic Obstr Pulm Dis20129290101
   Web of Science ®Google Scholar
• RennardSIScanlonPDFergusonGTACCORD COPD II: a randomized clinical trial to evaluate the 12-week efficacy and safety of twice-daily aclidinium bromide in chronic obstructive pulmonary disease patientsClin Drug Investig20133312893904
   PubMed Web of Science ®Google Scholar
• JonesPWSinghDBatemanEDEfficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN studyEur Respir J201240483083622441743
   PubMed Web of Science ®Google Scholar
• JonesPWLamarcaRChuecosFCharacterisation and impact of reported and unreported exacerbations: results from ATTAINEur Respir J20144451156116525234803
   PubMed Web of Science ®Google Scholar
• NiHSoeZMoeSAclidinium bromide for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev20149CD01050925234126
   PubMed Web of Science ®Google Scholar
• D’UrzoAKerwinERennardSHeTGilEGCaractaCOne-year extension study of ACCORD COPD I: safety and efficacy of two doses of twice-daily aclidinium bromide in patients with COPDChronic Obstr Pulm Dis2013104500510
   Web of Science ®Google Scholar
• GelbAFTashkinDPMakeBJLAS-MD-35 Study InvestigatorsLong-term safety and efficacy of twice-daily aclidinium bromide in patients with COPDRespir Med2013107121957196523916502
   PubMed Web of Science ®Google Scholar
• FuhrRMagnussenHSaremKEfficacy of aclidinium bromide 400 ug twice daily compared with placebo and tiotropium in patients with moderate to severe COPDChest2012141374575221903737
   PubMed Web of Science ®Google Scholar
• BeierJKirstenAMMrózREfficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb studyChronic Obstr Pulm Dis2013104511522
   Web of Science ®Google Scholar
• VestboJVogelmeierCCreemersJFalquesMRiberaAGilEGOnset of effect of aclidinium, a novel, long-acting muscarinic antagonist, in patients with COPDChronic Obstr Pulm Dis201075331336
   Web of Science ®Google Scholar
• MagnussenHWatzHZimmermannIPeak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPDRespir Med2009103121832183719651504
   PubMed Web of Science ®Google Scholar
• NewmanSPSuttonDJSegarraRLamarcaRde MiquelGLung deposition of aclidinium bromide from Genuair, a multidose dry powder inhalerRespiration200978332232819451700
   PubMed Web of Science ®Google Scholar
• van der PalenJGinkoTKrokerAPreference, satisfaction and errors with two dry powder inhalers in patients with COPDExpert Opin Drug Deliv20131081023103123745954
   PubMed Web of Science ®Google Scholar
• IsmailaACorriveauDVaillancourtJImpact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patientsCurr Med Res Opin20143071427143624666181
   PubMed Web of Science ®Google Scholar
• LaforestLLicajIDevouassouxGHartwigSMarvalinSVan GanseEFactors associated with early adherence to tiotropium in chronic obstructive pulmonary diseaseChron Respir Dis2013101111823149384
   PubMed Web of Science ®Google Scholar
• WurstKESt LaurentSMullerovaHDavisKJCharacteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort studyInt J Chron Obstruct Pulmon Dis201491021103125285002
   PubMed Web of Science ®Google Scholar
• de Miguel-DíezJJiménez-GarcíaRHernández-BarreraVClustering of unhealthy lifestyle behaviors is associated with a low adherence to recommended preventive practices among COPD patients in SpainChronic Obstr Pulm Dis2014114459467
   Web of Science ®Google Scholar
• VestboJAndersonJACalverleyPMAdherence to inhaled therapy, mortality and hospital admission in COPDThorax2009641193994319703830
   PubMed Web of Science ®Google Scholar
• van BovenJFTommeleinEBousseryKImproving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysisRespir Res2014156624929799
   PubMed Web of Science ®Google Scholar
• HuetschJCUmanJEUdrisEMAuDHPredictors of adherence to inhaled medications among veterans with COPDJ Gen Intern Med201227111506151222782274
   PubMed Web of Science ®Google Scholar
• ChrystynHSmallMMilliganGHigginsVGilEGEstruchJImpact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPDRespir Med2014108235836524209768
   PubMed Web of Science ®Google Scholar
• YuAPGuérinAPonce de LeonDTherapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalersJ Med Econ201114448649621679019
   PubMedGoogle Scholar
• AghTInotaiAMeszarosAFactors associated with medication adherence in patients with chronic obstructive pulmonary diseaseRespiration201182432833421454953
   PubMed Web of Science ®Google Scholar
• TrivediRBBrysonCLUdrisEAuDHThe influence of informal caregivers on adherence in COPD patientsAnn Behav Med2012441667222422104
   PubMed Web of Science ®Google Scholar
• CecereLMSlatoreCGUmanJEAdherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD)Chronic Obstr Pulm Dis201293251258
   Web of Science ®Google Scholar
• KhdourMRHawwaAFKidneyJCSmythBMMcElnayJCPotential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD)Eur J Clin Pharmacol201268101365137322476392
   PubMed Web of Science ®Google Scholar
• ViswanathanMGolinCEJonesCDInterventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic reviewAnn Intern Med20121571178579522964778
   PubMed Web of Science ®Google Scholar
• BorgGAPerceived exertion: a note on “history” and methodsMed Sci Sports19735290934721012
   PubMedGoogle Scholar
• GiftAGValidation of a vertical visual analogue scale as a measure of clinical dyspneaRehabil Nurs19891463233252813949
   PubMedGoogle Scholar
• GuyattGHBermanLBTownsendMPugsleySOChambersLWA measure of quality of life for clinical trials in chronic lung diseaseThorax198742107737783321537
   PubMed Web of Science ®Google Scholar
• JonesPWQuirkFHBaveystockCMThe St George’s respiratory questionnaireRespir Med199185suppl B2531 discussion 33–371759018
   PubMed Web of Science ®Google Scholar
• JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD assessment testEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• van der MolenTWillemseBWSchokkerSten HackenNHPostmaDSJuniperEFDevelopment, validity and responsiveness of the clinical COPD questionnaireHealth Qual Life Outcomes200311312773199
   PubMedGoogle Scholar
• HernandezPBalterMBourbeauJHodderRLiving with chronic obstructive pulmonary disease: a survey of patients’ knowledge and attitudesRespir Med200910371004101219269150
   PubMed Web of Science ®Google Scholar
• PartridgeMRMiravitllesMStahlEKarlssonNSvenssonKWelteTDevelopment and validation of the capacity of daily living during the morning questionnaire and the global chest symptoms questionnaire in COPDEur Respir J20103619610419897551
   PubMed Web of Science ®Google Scholar
• PommerAMPrinsLvan RanstDDevelopment and validity of the patient-centred COPD questionnaire (PCQ)J Psychosom Res201375656357124290047
   PubMed Web of Science ®Google Scholar
• BirringSSPrudonBCarrAJSinghSJMorganMDPavordIDDevelopment of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)Thorax200358433934312668799
   PubMed Web of Science ®Google Scholar
• PokrzywinskiRFMeadsDMMcKennaSPGlendenningGARevickiDADevelopment and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS)Health Qual Life Outcomes200979819968881
   PubMed Web of Science ®Google Scholar
• HareendranAPalsgroveACMocarskiMThe development of a patient-reported outcome measure for assessing nighttime symptoms of chronic obstructive pulmonary diseaseHealth Qual Life Outcomes20131110423799883
   PubMed Web of Science ®Google Scholar
• FiskJDRitvoPGRossLHaaseDAMarrieTJSchlechWFMeasuring the functional impact of fatigue: initial validation of the fatigue impact scaleClin Infect Dis199418suppl 1S79S838148458
   PubMed Web of Science ®Google Scholar
• Al-shairKKolsumUBerryPDevelopment, dimensions, reliability and validity of the novel Manchester COPD fatigue scaleThorax2009641195095519720608
   PubMed Web of Science ®Google Scholar
• WhiteheadLThe measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measuresJ Pain Symptom Manage200937110712819111779
   PubMed Web of Science ®Google Scholar
• ParshallMBSchwartzsteinRMAdamsLAmerican Thoracic Society Committee on DyspneaAn official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspneaAm J Respir Crit Care Med2012185443545222336677
   PubMed Web of Science ®Google Scholar
• WeldamSWSchuurmansMJLiuRLammersJWEvaluation of Quality of Life instruments for use in COPD care and research: a systematic reviewInt J Nurs Stud201350568870722921317
   PubMed Web of Science ®Google Scholar